Key result
Hip revision surgery with standardized thromboprophylaxis yielded a similar prevalence of thromboembolic events compared to primary hip arthroplasty.
Why the study?
Evidence regarding thromboprophylaxis in hip revision arthroplasty is scarce despite a potentially higher thromboembolic risk than in primary arthroplasty, leaving it uncertain whether primary recommendations yield similar results.
Does thromboprophylaxis recommended for primary hip arthroplasty produce similar thromboembolic outcomes in hip revision arthroplasty?
Cohort
Does thromboprophylaxis recommended for primary hip arthroplasty produce similar thromboembolic outcomes in hip revision arthroplasty?
Standardized thromboprophylaxis regimens for primary hip arthroplasty yield similar thromboembolic outcomes when applied to hip revision surgery, despite a higher risk of major bleeding.
Answers are grounded in this paper and cite their sources.
May support standard prophylaxis for revision hip arthroplasty; observational data leave bleeding risk adjustments open.
The risk of thromboembolic events after hip revision arthroplasty might be higher than in primary hip arthroplasty. However, evidence regarding the use of thromboprophylaxis in revisions is scarce. The purpose of this study is to determine whether thromboprophylaxis recommendations for primary arthroplasty produce similar results in hip revision arthroplasty. This comparative cohort study retrospectively analyzed consecutive patients undergoing primary hip arthroplasty and hip revision surgery between March 2004 and December 2015, who received thromboprophylaxis according to local clinical practice guidelines for primary hip arthroplasty. The prevalence of deep vein thrombosis and pulmonary embolism and the presence of major bleeding events were assessed during hospitalization and at 3 months after discharge and compared between groups. The overall prevalence of thromboembolic events in the hip revision surgery cohort and in the primary hip cohort was 1.62% and 1.35%, respectively ( P = .801). The 38.4% of hip revision patients and 20.3% of primary hip patients presented major bleeding events. Thromboembolic disease outcomes with the use of a standardized thromboprophylaxis regimen were similar in both cohorts, regardless of the high variability of hip revision surgery and the increased risk of complications. Implementation of this regimen is recommended in patients requiring joint replacement revision surgery.
No takes yet. Share an insight, caveat, or question.
Bautista et al. (2019) conducted a cohort in Hip revision arthroplasty. Hip revision arthroplasty vs. Primary hip arthroplasty was evaluated on Overall prevalence of thromboembolic events (p=.801). Hip revision surgery with standardized thromboprophylaxis yielded a similar prevalence of thromboembolic events compared to primary hip arthroplasty.
Synapse has enriched 10 related papers. Consider them for comparative context: